Searches , social queries for PSMA SCAN
Search references for PSMA SCAN. Phrases containing PSMA SCAN
See searches and references containing PSMA SCAN!
Search references for PSMA SCAN. Phrases containing PSMA SCAN
See searches and references containing PSMA SCAN!PSMA SCAN
Medical imaging technique
A PSMA scan is a nuclear medicine imaging technique used in the diagnosis and staging of prostate cancer. It is carried out by injection of a radiopharmaceutical
PSMA_scan
Nuclear medicine test that uses gallium to obtain images of tissues
'gallium scan'. Usually they are named after the addressed target or labeled bioligand, e.g., 'PSMA scan' or 'DOTATOC scan'. In the past, the gallium scan was
Gallium_scan
Medical imaging technique
(MIBG) scan. For prostate cancer, there is growing interest in using a PET scan with radionuclides delivered via prostate-specific membrane antigen (PSMA) targeting
Positron_emission_tomography
Male reproductive organ cancer
(worst prognosis). The extent of cancer spread is assessed by MRI or PSMA scan – a positron emission tomography (PET) imaging technique where a radioactive
Prostate_cancer
Radiopharmaceutical medication
Gallium (68Ga) PSMA-11, is a radiopharmaceutical made of 68Ga conjugated to a inhibitor of the enzyme prostate-specific membrane antigen (PSMA) known as
Gallium_(68Ga)_gozetotide
Radioactive biochemical substance used for diagnosis or for study of receptor systems
study: Efficacy and safety of PSMA-targeted radioligand therapy I-131-1095 (1095) plus enzalutamide (enza) in 18F-DCFPyL PSMA scan avid, metastatic castration-resistant
Radioligand
France-based pharmaceutical group
pulmonary indications. 177Lu-PSMA-617 and 68Ga-PSMA-617 are in development to treat, image, monitor and stage prostate cancer. PSMA-617 is a ligand of prostate-specific
Advanced Accelerator Applications
Advanced_Accelerator_Applications
Enzyme
randomised phase 3 trial ("ProPSMA study") was published comparing Gallium-68 PSMA PET/CT to standard imaging (CT and bone scan). This 300 patient study conducted
Glutamate_carboxypeptidase_II
Chemical compound
It is the second PSMA-targeted PET imaging drug approved by the U.S. Food and Drug Administration (FDA). The first approved PSMA-targeted PET imaging
Piflufolastat_(18F)
American physician and researcher
mAbs and PSMA-targeted PET imaging, they accurately identified cancer spread. Their work laid the foundation for the now standard PSMA PET scan. They were
Neil_H._Bander
of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE". EJNMMI Radiopharmacy and Chemistry. 6 (1) 1. doi:10
Isotopes_of_gallium
Isotope of indium
dosimetry estimates prior to 90Y immunotherapy for lymphoma 111In ProstaScint — PSMA antibody imaging of prostate cancer 111In pentetreotide (including in 111In
Indium-111
Pair of salivary glands behind the nasal cavity
Netherlands Cancer Institute in September 2020 using PET/CT scans in patients injected with PSMA-tracer. Tubarial glands are packed with predominantly mucinous
Tubarial_salivary_gland
Medical condition
Flamen P (May 2017). "Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga-PSMA Ligand PET/CT". Clinical Nuclear Medicine. 42 (5): 368–370. doi:10.1097/RLU
Vertebral_hemangioma
Medical condition
Yongxiang; Yin, Hongling; Hu, Shuo (2021). "18F-PSMA-1007 PET/CT uptake in multiple angiolipomas caused by PSMA expression in capillaries: a case report".
Angiolipoma
Eight amino-acid long peptide covalently bonded to a DOTA chelator
Emmett L, Willowson K, Violet J, Shin J, Blanksby A, Lee J (March 2017). "177 PSMA radionuclide therapy for men with prostate cancer: a review of the current
DOTA-TATE
Medical diagnostic method
177Lu-PSMA or 225Ac-PSMA therapies. For local recurrence, 68Ga-PSMA PET/MR or PET/CT in combination with mpMR is most appropriate. PSMA PET/CT may be potentially
Prostate_cancer_screening
American technology company
location intelligence tool, called GeoVision, which uses data provided by PSMA Australia and allows companies to "visualise, analyse, and ultimately make
Pitney_Bowes
Pharmaceutical drug which emits radiation, used as a diagnostic or therapeutic agent
period to prepare the radiopharmaceutical and trace it, such as a fibrinogen scan to diagnose clotting. I-125's gamma radiation is of medium penetration, making
Radiopharmaceutical
Type of radiotherapy
Excellence. 29 August 2018. Retrieved 3 September 2018. Kabasaka, Levent. "Lu-177-PSMA Real World Clinical Study: Out-patient or In-patient Treatment" (PDF). BNMS
Peptide receptor radionuclide therapy
Peptide_receptor_radionuclide_therapy
Iranian specialist in Nuclear Medicine (born 1963)
diagnostics. Mirzaei and his team are the first center which is applying Cu-64 PSMA in prostate cancer. Somatostatin receptor scintigraphy (SRS) and therapy
Siroos_Mirzaei
Visualization of living animals for research purposes
Positron-emitting and Fluorescent (HD-GPF) reporter system uses a human protein, PSMA and non-immunogenic, and a small molecule that is positron-emitting (boron
Preclinical_imaging
Leonardo Lima; Lemos, Gustavo Caserta (2020-02-24). "Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate
Arterial_input_function
American physician
Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021). "Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer". New England Journal
Chandler_Park
Common type of liver cancer
treatment. Results from Phase 2 trial recommended G-202 as a first-in-class PSMA-targeted prodrug and that it move to clinical trials. Current research includes
Hepatocellular_carcinoma
travel, tourism, insurance
PSMA SCAN
PSMA SCAN
PSMA SCAN
PSMA SCAN
PSMA SCAN
PSMA SCAN
PSMA SCAN
PSMA SCAN
PSMA SCAN
travel, tourism, insurance